Search

Author/Creator Mangia, A.

1. A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B. Issue 5 (2nd July 2018)

Authors:
El Sharkawy, R.; Thabet, K.; Lampertico, P.; Petta, S.; Mangia, A.; Berg, T.; Metwally, M.; Bayoumi, A.; Boonstra, A.; Brouwer, W. P.; Smedile, A.; Abate, M. L.; Loglio, A.; Douglas, M. W.; Khan, A.; Santoro, R.; Fischer, J.; Leeming, D. J.; Liddle, C.; George, J.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 48:Issue 5(2018)
Page Start:
564
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Changing HCV patient profiles: insights from a large multinational real-world sofosbuvir/velpatasvir (SOF/VEL) dataset. (March 2023)

Authors:
Mangia, A.; Fagiuoli, S.; Di Marco, V.; Shafran, S.; Khalili, M.; Milligan, S.; Papatheodoridis, G.; Ouzan, D.; Rosati, S.; Ramji, A.; Teti, E.; Garcia-Retortillo, M.; Hernandez, F. Andres Perez; Wong, A.; Fraser, C.; Rodriguez-Tajes, S.; Mutiloa, E. Jimenèz; Amado, L. Enrique Morano; O'Loan, J...
Journal:
Digestive and liver disease
Issue:
Volume 55(2023)Supplement 1
Page Start:
S71
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Effect of hepatitis B virus on steatosis in hepatitis C virus co‐infected subjects: A multi‐centre study and systematic review. Issue 8 (17th April 2018)

Authors:
Goossens, N.; de Vito, C.; Mangia, A.; Clément, S.; Cenderello, G.; Barrera, F.; D'Ambrosio, R.; Coppola, N.; Zampino, R.; Stanzione, M.; Adinolfi, L. E.; Wedemeyer, H.; Semmo, N.; Müllhaupt, B.; Semela, D.; Malinverni, R.; Moradpour, D.; Heim, M.; Trincucci, G.; Rubbia‐Brandt, L.
Other Names:
Piazzolla Valeria investigator.; Santoro Rosanna investigator.; Dufour Jean‐Francois investigator.; Brunner Barbara investigator.; Weber Achim investigator.; Herranz Maribelle investigator.; Mathieu Adeline investigator.; Clerc Olivier investigator.; Elisabetta Degasperi investigator.; Floriana F...
Journal:
Journal of viral hepatitis
Issue:
Volume 25:Issue 8(2018)
Page Start:
920
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Extension of Bulevirtide monotherapy to 72 weeks in HDV patients with compensated cirrhosis: Efficacy and safety from the italian multicenter study (HEP4Di). (March 2023)

Authors:
Anolli, M.P.; Degasperi, E.; D'Offizi, G.; Brunetto, M.R.; Verucchi, G.; Federico, A.; Ciancio, A.; Mangia, A.; Santantonio, T.A.; Coppola, N.; Pellicelli, A.; Loglio, A.; Viganò, M.; Pileri, F.; Maracci, Monia; Puoti, M.; Piscaglia, F.; Lampertico, P.
Journal:
Digestive and liver disease
Issue:
Volume 55(2023)Supplement 1
Page Start:
S7
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. (17th December 2015)

Authors:
Di Maio, V. C.; Cento, V.; Di Paolo, D.; Aragri, M.; De Leonardis, F.; Tontodonati, M.; Micheli, V.; Bellocchi, M. C.; Antonucci, F. P.; Bertoli, A.; Lenci, I.; Milana, M.; Gianserra, L.; Melis, M.; Di Biagio, A.; Sarrecchia, C.; Sarmati, L.; Landonio, S.; Francioso, S.; Lambiase, L.
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 71:Number 3(2016:Mar.)
Page Start:
739
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Intrapatient viral diversity and treatment outcome in patients with genotype 3a hepatitis C virus infection on sofosbuvir‐containing regimens. Issue 4 (28th December 2017)

Authors:
Bhardwaj, N.; Ragonnet‐Cronin, M.; Murrell, B.; Chodavarapu, K.; Martin, R.; Chang, S.; Miller, M. D.; Feld, J. J.; Sulkowski, M.; Mangia, A.; Wertheim, J. O.; Osinusi, A.; McNally, J.; Brainard, D.; Mo, H.; Svarovskaia, E. S.
Journal:
Journal of viral hepatitis
Issue:
Volume 25:Issue 4(2018)
Page Start:
344
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Randomised clinical trial: sofosbuvir and ledipasvir in patients with transfusion‐dependent thalassaemia and HCV genotype 1 or 4 infection. Issue 4 (29th June 2017)

Authors:
Mangia, A.; Sarli, R.; Gamberini, R.; Piga, A.; Cenderello, G.; Piazzolla, V.; Santoro, R.; Caruso, V.; Quarta, A.; Ganga, R.; Copetti, M.; Forni, G.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 46:Issue 4(2017)
Page Start:
424
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗